Pages that link to "Q68472111"
Jump to navigation
Jump to search
The following pages link to Extrarenal complications of the nephrotic syndrome (Q68472111):
Displaying 33 items.
- Renal apolipoproteins in nephrotic rats (Q28378715) (← links)
- Macrophages from nephrotic rats regulate apolipoprotein E biosynthesis and cholesterol content independently. (Q34180503) (← links)
- Patient age and the prognosis of idiopathic membranous nephropathy (Q34374122) (← links)
- What has the immune system got against the glomerular podocyte? (Q35219282) (← links)
- Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome (Q35606562) (← links)
- Proteinuria in dogs and cats (Q35967679) (← links)
- Management of nephrotic syndrome in childhood (Q36691433) (← links)
- Hepatic infarction: an unusual complication of nephrotic syndrome in a patient with diabetes mellitus (Q36724027) (← links)
- Membranous nephropathy in the older adult: epidemiology, diagnosis and management (Q36922222) (← links)
- Minimal change nephropathy and focal segmental glomerulosclerosis (Q36978935) (← links)
- Platelet functions and coagulation changes in Indian children with nephrotic syndrome (Q37197135) (← links)
- Lipid abnormalities in renal disease (Q37660663) (← links)
- Complications of nephrotic syndrome (Q39017396) (← links)
- Oncotic pressure and edema formation in hypoalbuminemic HIV-infected patients with proteinuria (Q39457133) (← links)
- Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment (Q40725226) (← links)
- Hyperlipidemia in childhood nephrotic syndrome (Q40785460) (← links)
- A review of the hypercoagulable state. (Q40807893) (← links)
- Hepatic cholesterol metabolism in experimental nephrotic syndrome (Q42544371) (← links)
- Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome (Q44470928) (← links)
- Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats (Q45090910) (← links)
- Mechanisms and management of nephrotic edema (Q46192208) (← links)
- Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome. (Q55509896) (← links)
- Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats (Q57791601) (← links)
- Clinical and histopathologic findings in adults with the nephrotic syndrome (Q57828146) (← links)
- Nephrotic Proteinuria Without Hypoalbuminemia: Clinical Characteristics and Response to Angiotensin-Converting Enzyme Inhibition (Q61456204) (← links)
- Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency (Q68104220) (← links)
- Thrombocytosis after cyclosporin therapy in child with nephrotic syndrome (Q69925157) (← links)
- Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?) (Q71448711) (← links)
- Nephrotic syndrome, nephromegaly, renal hyperfiltration, and sudden death in a diabetic woman (Q71552170) (← links)
- Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease (Q72809754) (← links)
- Minimal change nephrotic syndrome in children with intrauterine growth retardation (Q73812627) (← links)
- Pathogenesis and Management of Acute Kidney Injury in Patients with Nephrotic Syndrome Due to Primary Glomerulopathies (Q92127815) (← links)
- Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: A case report (Q92367680) (← links)